Insider · CIK 0001509643

THOMPSON JOHN CRAIG

Reports to the SEC for 4 companies · ANN ARBOR, MI

sec.gov

Transactions

Companies

Filings

CIK

0001509643

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-13	ESPREsperion Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−79.9K sh	—	—	0
2026-07-13	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2026-05-28	ESPREsperion Therapeutics, Inc.A Award	Director	AAward	+79.9K sh	—	—	79,873
2025-07-01	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2017-09-20	Anthera Pharmaceuticals IncP Purchase	Director, President & CEO	PPurchase	+8,550 sh	$1.32	+$11.3K	19,848
2017-09-07	Anthera Pharmaceuticals IncM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10.4K sh	$1.43	+$14.9K	17,590
2017-09-07	Anthera Pharmaceuticals IncP Purchase	Director, President & CEO	PPurchase	+10.4K sh	$1.43	+$14.9K	11,298
2017-05-20	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Director, President & CEO	AAward	+81.3K sh	—	—	81,250
2017-03-03	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Director, President & CEO	AAward	+100K sh	—	—	100,000
2017-01-11	Anthera Pharmaceuticals IncA Award	Director, President & CEO	AAward	+7,190 sh	$0.55	+$3,954.5	7,190
2016-12-06	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Director, President & CEO	AAward	+200K sh	—	—	200,000
2016-12-06	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Director, President & CEO	AAward	+300K sh	—	—	300,000
2016-06-09	Anthera Pharmaceuticals IncStock option (right to buy)A Award	Director, President & CEO	AAward	+170K sh	—	—	170,000
2015-09-08	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$14.45	+$145K	10,343
2015-09-08	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−10K sh	$44.08	−$441K	343
2015-09-08	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	157,501
2015-08-05	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$14.45	+$145K	10,343
2015-08-05	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−10K sh	$46.31	−$463K	343
2015-08-05	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	167,501
2015-07-06	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$14.45	+$145K	10,343
2015-07-06	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−10K sh	$47.91	−$479K	343
2015-07-06	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	177,501
2015-06-15	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$14.45	+$145K	10,343
2015-06-15	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−10K sh	$41.51	−$415K	343
2015-06-15	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	187,501
2015-06-08	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+22.5K sh	$14.45	+$325K	22,842
2015-06-08	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−11.9K sh	$43.50	−$516K	10,980
2015-06-08	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−10.6K sh	$43.00	−$457K	343
2015-06-08	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−22.5K sh	—	—	197,501
2015-05-15	TETRAPHASE PHARMACEUTICALS INCM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+30K sh	$14.45	+$434K	30,343
2015-05-15	TETRAPHASE PHARMACEUTICALS INCS Sale	Chief Operating Officer	SSale	−30K sh	$39.63	−$1.19M	343
2015-05-15	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−30K sh	—	—	220,000
2015-01-07	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+100K sh	—	—	100,000
2014-02-03	TETRAPHASE PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+250K sh	—	—	250,000
2013-09-11	Trius Therapeutics IncD Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−2,455 sh	—	—	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−150K sh	$9.20	−$1.38M	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−90K sh	$8.70	−$783K	0
2013-09-11	Trius Therapeutics IncStock Option (right to buy)D Disposition to Issuer	Chief Commercial Officer	DDisposition to Issuer	−125K sh	$7.37	−$921K	0
2013-03-07	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Commercial Officer	AAward	+125K sh	—	—	125,000
2012-03-08	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Commercial Officer	AAward	+90K sh	—	—	90,000
2011-08-22	Trius Therapeutics IncP Purchase	Chief Commercial Officer	PPurchase	+133 sh	$6.48	+$861.84	133
2011-01-10	Trius Therapeutics IncStock Option (right to buy)A Award	Chief Commercial Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Jul 134
THOMPSON JOHN CRAIG0001628280-26-048006
SEC(opens sec.gov)
Jun 14
THOMPSON JOHN CRAIG0001628280-26-039529
SEC(opens sec.gov)
Jul 24
THOMPSON JOHN CRAIG0001628280-25-033839
SEC(opens sec.gov)
Sep 204
THOMPSON JOHN CRAIG0001214659-17-005694
SEC(opens sec.gov)
Sep 74
THOMPSON JOHN CRAIG0001214659-17-005528
SEC(opens sec.gov)
Sep 74/A
THOMPSON JOHN CRAIG0001214659-17-005550
SEC(opens sec.gov)
May 224
Anthera Pharmaceuticals Inc0001214659-17-003557
SEC(opens sec.gov)
Mar 34/A
Anthera Pharmaceuticals Inc0001214659-17-001675
SEC(opens sec.gov)
Mar 34
Anthera Pharmaceuticals Inc0001214659-17-001676
SEC(opens sec.gov)
Feb 65
Anthera Pharmaceuticals Inc0001214659-17-000747
SEC(opens sec.gov)
Dec 64
Anthera Pharmaceuticals Inc0001214659-16-015225
SEC(opens sec.gov)
Jun 134
Anthera Pharmaceuticals Inc0001214659-16-012180
SEC(opens sec.gov)
Sep 104
TETRAPHASE PHARMACEUTICALS INC0001209191-15-070267
SEC(opens sec.gov)
Aug 74
TETRAPHASE PHARMACEUTICALS INC0001209191-15-064734
SEC(opens sec.gov)
Jul 84
TETRAPHASE PHARMACEUTICALS INC0001209191-15-060151
SEC(opens sec.gov)

Companies

Address

C/O ESPERION THERAPEUTICS, INC. 3891 RANCHERO DRIVE, SUITE 150

ANN ARBOR, MI, 48108